LABCORP HOLDINGS INC. — Director's Dealing 2020

Nov 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-11-05

Reporting Person: Schroeder Mark S (EVP, President-Diagnostics Lab)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-05	Common Stock	M	2010	—	Acquired	5372.3789	Direct
2020-11-05	Common Stock	F	835	$214.42	Disposed	4537.3789	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-05	Restricted Stock Unit	$	M	2010	Disposed		Common Stock (2010)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Amount includes 149.0224 shares acquired on June 30, 2020 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.

F3: Stock withholding to satisfy tax withholding obligations.

F4: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on November 5, 2020.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.